Impact Dashboard - August 2014
|
|
- Elwin Jenkins
- 5 years ago
- Views:
Transcription
1 Impact Dashboard - By, PSI and its network members averted an estimated 29.7 million DALYs globally. PSI has met 53.3% of the strategic plan (SP) target to avert million DALYs, and 53.0% of the SP target to provide million CYPs; with 53.3% elapsed time DALYs averted from nine countries accounted for 77% of DALYs averted and each accounted for > 1 millions DALYs averted, see page 3. DALYs averted from sold, male condoms are lagging 14% behind the 2014 target and distribution has decreased 22% relative to 2013, note India and Congo-Kinshasa. By far, our biggest CYP producers are Nigeria, Kenya, and Pakistan; total of 41% of CYPs provided and each accounted for > 1 million CYPs, see page 5. PSI PROGRESS ON SCALE August SP to date SP Target % SP Target DALYs 3,507,662 29,677,871 17% 105,971, ,700, % CYPs 1,606,850 12,413,763-18% 55,971, ,600, % PSI Health Relevance 24.73% PSI Burden 1.59% PSI PROGRESS TOWARD STRATEGIC PLAN (SP) TARGETS IN DALYS AVERTED AND CYPS PSI 2014 Target: 25% increase in DALYs averted relative to Target: 30% increase in CYPs relative to Million ion DALYs averted Baseline (158.9 million DALYs averted) Performance (106.0 million DALYs averted) Million ion CYPs Provided SP Target 20 (198.7 million DALYs averted) - PSI REGIONAL AND HEALTH AREA PERFORMANCE Region August DALYs DALYs % of 2014 Program Target* CYPs Provided Baseline (81.3 million CYPs) Strategic Plan Time Elapsed 53.3% (32/60 months) Performance (56.0 million CYPs) SP Target (105.6 million CYPs) % of 2014 Program Target* West & Central Africa 1,691,939 14,622,821 48% 70% 413,734 3,212,878-25% 55% East Africa 959,308 7,932,291-10% 78% 528,464 3,810,761 37% 90% Southern Africa 711,617 5,917,666 35% 58% 321,764 2,288,601 7% 64% Latin America & Caribbean 13, ,877-1% 62% 59, ,340 0% 60% Asia & Eastern Europe 131,718 1,098,217-49% 33% 283,761 2,616,183-52% 32% TOTAL 3,507,662 29,677,871 17% 66% 1,606,850 12,413,763-18% 55% Health Area August DALYs DALYs Burden HIV, STD, Hepatitis B&C, Opioid Use 980,272 7,117,557 5% 51 of % Tuberculosis 13,866 93,929 4% 8 of % Reproductive Health 670,932 5,085,568-13% 52 of % Malaria 1,775,624 16,723,446 46% 27 of % Diarrhea Diseases 33, ,321 11% 29 of % Nutritional Deficiencies % 6 of % Respiratory Infections 33, ,830-64% 5 of % Health areas not targeted by PSI TOTAL 3,507,662 29,677,871 17% 1.59% * 2014 program targets: 44,748,981 DALYs averted and 22,655,582 CYPs; we should be at 67% in August August CYPs Provided Country with Program Burden as % of PSI Global 6.81% 2.66% 8.14% 5.43% 5.25% 2.33% 5.95% 63.41% IMPACT DASHBOARD AUGUST
2 PSI PROGRESS ON RELEVANCE SP Target Health Relevance 24.73% 42% FP Method Mix* 52.8% (28 of 53)** 75% Mali (added burden from tuberculosis - referral to TB diagnostic) No change Notes: start reporting in this period *% platforms offering 4 or more FP modern methods with at least one long-term method (LTM), ** excluded C.A.R., China, Cote d'ivoire (AIMAS), Mexico, and Romania PSI RELEVANCE: 2010 Global Burden of Disease < Expansion & Innovation > 90% 80% 70% 60% 50% 40% 30% Current works 20% 10% 0% PSI Global Innovation in Other Health Areas: % disease burden not targeted by PSI Expansion: % disease burden targeted by existing PSI products/services plus cervical cancer, diabetes mellitus, and high blood pressure, not in use by country platform Health Relevance: % disease burden targeted by current country platform products and services Burden : % DALYs averted by PSI in 2014 as proportion of 2010 Global Burden of Disease in DALYs 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Mozambique Zimbabwe Cameroon Nigeria Zambia Swaziland Madagascar Tanzania South Africa Malawi Uganda Mali Lesotho DRC Kenya Botswana Guinea Benin Rwanda South Sudan Angola Myanmar Burundi Namibia Senegal Togo Côte d'ivoire Liberia Caribbean Pakistan India Belize Cambodia Ethiopia PNG Laos Thailand Dom Rep Guatemala Honduras Viet Nam Panama Nicaragua Tajikistan Paraguay El Salvador Kyrgyzstan yzstan Nepal Haiti Kazakhstan Costa Rica Russia PSI FP Method Mix: classified by modern method mix. FP method mix targets 4 methods + 1 long-term method (LTM) 4 or more modern methods + 1 LTM 4 or more modern methods + 1 LTM 2 modern methods Madagascar Ethiopia Papua New Guinea Nigeria Rwanda Somaliland Pakistan El Salvador South Africa Benin Nicaragua Swaziland Congo-Kinshasa Haiti Thailand Malawi India 1 short-term method Mali Laos Botswana Myanmar Liberia Costa Rica Tanzania 3 modern methods Cote d'ivoire Togo Dominican Republic Honduras Zimbabwe Nepal Kazakhstan Cambodia Belize Panama Cameroon Guinea South Sudan Mozambique Paraguay Tajikistan Uganda Senegal Vietnam Zambia 2 modern methods no FP method provided Burundi Angola Russia Guatemala Kyrgyzstan Kenya Lesotho Caribbean Namibia number of long-term methods including implants, IUDs and male/female sterilization number of short-term methods including male condom, female condom, cycle beads, EC, injectables and OC IMPACT DASHBOARD AUGUST
3 COUNTRIES BY 2014 DALYS AVERTED DALYs DALYs % of 2014 DALYs Health Relevance DALYs %DALYs Nigeria 1,584,968 9,059,409 41% 93% 44.18% 24,447, % Congo-Kinshasa 7,489 3,926, % 52% 36.02% 12,832, % South Sudan 269,496 1,764,829-48% 84% 31.99% 8,362, % Zimbabwe 147,626 1,764, % 47% 45.67% 5,202, % South Africa 260,844 1,455,006-3% 60% 42.59% 6,012, % Uganda 171,198 1,336, % 78% 40.64% 3,495, % Kenya 78,809 1,312,221 91% 109% 35.38% 3,451, % Zambia 120,885 1,181,404 26% 54% 44.16% 4,928, % Tanzania 199,618 1,066,819-7% 65% 42.64% 3,861, % Mozambique 39, ,698-25% 69% 48.88% 3,890, % Mali 14, ,916 39% 36% 40.55% 3,732, % Madagascar 67, ,975 18% 74% 42.82% 4,157, % Malawi 91, ,313-51% 60% 41.95% 3,654, % Pakistan 34, ,307-47% 35% 19.82% 2,519, % Angola 42, , % 112% 31.42% 956, % Cameroon 56, ,637 24% 70% 44.69% 1,213, % Lesotho 77, ,909 38% 123% 37.85% 870, % Myanmar 39, ,473-35% 52% 31.24% 1,234, % Ethiopia 23, ,521-18% 58% 16.37% 980, % Swaziland 26, ,651 50% 78% 43.23% 718, % India 36, ,711-64% 19% 19.34% 2,542, % Benin 19, ,988 21% 69% 32.62% 555, % Rwanda 24, ,641 13% 61% 32.02% 638, % Burundi 16, ,591 65% 73% 30.09% 366, % Botswana 3, , % 189% 34.38% 311, % Guinea 5, ,570-90% 69% 32.89% 1,508, % Cambodia 11,626 95,142-44% 47% 18.83% 673, % Togo 1,020 56,773-13% 43% 28.40% 247, % Senegal 1,590 47,908 69% 61% 29.30% 114, % Namibia 7,712 38,815-68% 45% 29.56% 204, % Haiti 3,170 27,960-6% 62% 5.01% 159, % Guatemala 4,533 27,615 1% 56% 8.87% 117, % Dominican Republic 2,309 22,017 3% 66% 9.06% 86, % Somaliland 2,344 16,587 1% 62% NA 57, % Cote d'ivoire 1,201 16,082-23% 70% 23.53% 581, % Viet Nam 2,216 15,396 29% 64% 8.17% 83, % Tajikistan 4,935 12,448 66% 102% 7.48% 28, % Laos 1,862 10,151 3% 64% 13.47% 37, % Thailand 701 9,874 30% 58% 9.16% 36, % Nepal 348 9,072-80% 14% 5.57% 143, % Panama 494 6,379 22% 89% 7.91% 19, % Papua New Guinea 275 5,681 70% 98% 13.73% 22, % Paraguay 692 5,386-1% 61% 7.00% 20, % Honduras 694 5,139-4% 63% 8.33% 20, % El Salvador 544 5,136 3% 67% 6.87% 23, % Nicaragua 465 4,895 4% 61% 7.58% 20, % Liberia 3,030-13% 34% 21.35% 14, % Kazakhstan 1 2, % 99% 3.79% 15, % Belize % 51% 19.06% 4, % Costa Rica % 55% 3.06% 2, % Caribbean % 40% 20.35% 3, % Kyrgyzstan 28-29% 6.49% 16, % Russia 0 NA NA 0.00% % PSI GLOBAL 3,507,662 29,677,871 17% 66% 24.73% 105,971,074 * 2014 program targets: 44,748,981 DALYs averted; we should be at 67% in August. 5 Company 158** 94, ,705 12% NA NA 2,496, % **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD AUGUST
4 PSI PRODUCTS & SERVICES BY 2014 DALYS AVERTED 0% Products / Services DALYs DALYs % of 2014 DALYs # Distributed Reporting 2014 CYPs LLIN 774,671 10,108,096 88% 65% 19,368, Malaria PPT (ACT) 1,000,710 6,608,435 10% 81% 11,426, Condom 690,586 5,020,934-14% 53% 512,448, ,270,403 Free Condom 262,480 2,011,487 17% 82% 162,134, ,351,121 Male Circumcision 185, ,616 21% 76% 273,228 9 Basic Care Package 46, , % 67% 14,078,163 2 OC 71, ,181-22% 58% 23,368, ,557,914 IUD 10 Insertion 86, ,083 4% 90% 236, ,087,601 Injectable 3 35, ,584-7% 63% 4,992, ,248,244 HIV Counseling and Testing 44, ,272-10% 63% 1,422, Implant 5 Insertion 58, ,959 42% 176% 188, ,497 Pneumonia PPT 33, ,830-64% 71% 448,088 5 IUD 10 Distribution 56, ,763-27% 40% 71, ,583 Implant 3 Distribution 15, , % 604% 157, ,783 IUD 5 Insertion 22, ,893-6% 986% 131, ,069 IUD 5 Distribution 12, ,600-74% 18% 139, ,597 Diarrhea Treatment Kit 12, ,826 14% 51% 1,803, ORS 3, ,531 82% 110% 3,319,634 7 Safe Water Solution 12,277 97,568-28% 58% 6,937, TB DOTS 13,866 93,929 4% 66% 15,804 4 Female Condom 6,148 84,684 15% 86% 6,357, ,980 Injectable 2 9,529 75,972-9% 45% 948, ,034 Emergency Contraception 4,223 39,820 18% 39% 2,100, ,022 Implant 3 Insertion 8,584 39, % 98% 27, ,083 SDM (Cycle Beads) 3,214 38,491 16% 65% 52, ,394 Implant 5 Distribution 8,267 26,150-81% 9% 15, ,796 Needle & Syringe 4,669 24, % 75% 2,982,705 4 Water Treatment Tablets 3,730 23,054 11% 70% 47,774, STI Kit 6,795 19, % 111% 402,429 6 Free Female Condom 1,887 14,109-47% 57% 992, ,270 Misoprostol for PAC (Oral) 2,424 13,601-14% 43% 796,313 5 Zinc , % 320% 1,032,584 4 Medication Abortion 1,178 9,776-20% 59% 312,597 3 Naloxone 2,729 7,912 2% 80% 5,813 2 Tubal Ligation 5,404-66% 9% 1, ,230 Early Infant MC 884 5,141-47% 35% PUR 245 4,872-28% 77% 31,184, Injectable ,582-26% 44% 163, ,607 Malaria PPT (Non-ACT) 162 3,426-16% 60% 40,200 1 Retreatment IconMaxx 3,243-94% NA 21,519 1 Implant 4 Insertion 395 2,937 87% 12% 2, ,152 Clean Delivery Kit 84 2,661-26% 52% 35,056 5 Misoprostol for PPH 379 2,212 45% 201% 489,026 3 Skilled Birth Attendance (Facility Deliv 527 1, % NA 8,442 1 LifeStraw 0 1, % 1020% 7,843 1 Antiretroviral Treatment (Patient-mont % 37% 1,479 1 Cervical Cancer-VIA/PAP & Cryothe % 36% 1,418 8 IPTp % 0% 5,815 1 Multivitamin % 73% 1,940,640 2 Implant 4 Distribution , % -147% -1, ,616 Iron Folic Acid Tablet 0 - NA 0 0 Malaria RDK 0 NA NA 2,790,525 9 Micronutrient Powder 0 NA NA 1,661,140 3 Vasectomy 0% NA 0% 0 PSI GLOBAL 3,507,662 29,677,871 17% 66% 12,413,763 * 2014 program targets: 44,748,981 DALYs averted; we should be at 67% in August. IMPACT DASHBOARD AUGUST
5 COUNTRIES BY 2014 CYPS PROVIDED ## CYPs CYPs % of 2014 CYPs FP Method Mix CYPs Provided % of CYPs Provided Nigeria 320,346 2,228,364 5% 60% 8,676, % Kenya 99,497 1,498, % 127% 3,523, % Pakistan 92,575 1,315,718-48% 34% 7,052, % Tanzania 183, ,755-16% 65% 3,845, % South Africa 140, ,558-5% 58% 3,223, % Uganda 173, , % 120% 1,961, % Madagascar 72, ,868 10% 72% 2,618, % India 95, ,242-68% 20% 6,745, % Cambodia 45, ,439-14% 49% 1,919, % Zambia 31, ,652-2% 46% 1,469, % Myanmar 43, ,980-42% 58% 1,617, % Zimbabwe 31, ,622 31% 62% 829, % Mali 21, ,073-66% 41% 1,446, % Cameroon 27, ,359 13% 54% 848, % Benin 26, ,458 20% 73% 722, % Ethiopia 12, ,192-22% 58% 688, % Malawi 14, ,868 15% 108% 425, % Lesotho 37, ,520 40% 132% 382, % Guatemala 19, ,049 0% 52% 554, % Mozambique 17, ,278 15% 48% 464, % Congo-Kinshasa 7,062 92,137-79% 23% 1,401, % Dominican Republic 9,180 87,935 3% 66% 344, % Guinea 5,222 85,961 16% 59% 389, % Rwanda 15,245 83,733 13% 59% 330, % Haiti 9,793 83,118-6% 59% 315, % Togo 1,207 71,388-47% 47% 417, % Botswana 1,587 65, % 189% 159, % Swaziland 2,228 57, % 102% 165, % Senegal 4,353 57,810-6% 53% 204, % Paraguay 7,275 54,557 0% 61% 210, % Nicaragua 4,426 45,599 4% 59% 197, % Burundi 3,972 34,788 64% 62% 96, % El Salvador 3,159 32,943-6% 69% 179, % Laos 5,927 31,047-7% 56% 125, % Angola 8,198 29,296 20% 81% 131, % Panama 1,949 25,737 22% 89% 77, % Namibia 4,259 21,383-68% 46% 111, % Honduras 2,732 20,158-4% 63% 80, % Nepal ,518-86% 9% 412, % Thailand 207 7,740 80% 61% 28, % Costa Rica 868 6,163-3% 52% 25, % Cote d'ivoire 430 5,099-26% 121% 16, % South Sudan 4,452-72% NA 67, % Tajikistan 665 4,002 35% 64% 10, % Liberia 3,229 10% 35% 14, % Papua New Guinea 316 3,187-13% 69% 17, % Caribbean 0 2,081 68% 39% 13, % Somaliland 367 1,715 7% 65% 6, % Belize 1,000-17% 51% 5, % Kazakhstan % 89% % Kyrgyzstan 88-99% 71% 37, % Viet Nam 46-18% 169, % Russia NA NA 0.0% PSI GLOBAL 1,606,850 12,413,763-18% 55% 55,971,986 * 2014 program targets: 22,655,582 CYPs; we should be at 67% in August. Company 158** 54, ,431 11% NA 1,434, % **included sales / distribution in Botswana, Lesotho, South Africa, and Swaziland. These sales / distribution are also included in the countries above. IMPACT DASHBOARD AUGUST
Impact Dashboard - October 2014
Impact Dashboard - 2014 By 2014, PSI and its network members averted an estimated 44.2 million DALYs globally. PSI has met 60.6% of the strategic plan (SP) target to avert 198.7 million DALYs, and 56.4%
More informationimpact dashboard year-end with 2017 coefficients
impact dashboard - 2017 year-end with 2017 coefficients In 2017, PSI averted an estimated 30.5 million DALYs and provided 20 million CYPs globally. PSI met global 2017 program targets for DALYs averted
More informationimpact dashboard - september 2018
impact dashboard - september 2018 PSI 2015 As of, PSI averted an estimated 17.1 M DALYs, provided 12.5 M CYPs, and reached 18.4 M users globally. Globally PSI has reached at least 18.4 million users across
More informationimpact dashboard - august 2018
impact dashboard - august 2018 PSI 2015 As of August, PSI averted an estimated 15.2 M DALYs, provided 10.9 M CYPs, and reached 16.7 M users globally. Globally PSI has reached at least 16.7 million users
More informationimpact dashboard - june 2018
impact dashboard - june 2018 As of June, PSI averted an estimated 11.3 M DALYs, provided 8.1 M CYPs, and reached 12.5 M users globally. Ethiopia, Zambia, and Cameroon have made considerable progress on
More informationimpact dashboard - may 2018
impact dashboard - may 2018 As of May, PSI averted an estimated 8.0 M DALYs, provided 6.2 M CYPs, and reached 8.1 M users globally. In May alone, PSI added 2.6 M users toward the goal of 90 M reached by
More informationOctober 2011 Monthly Health Impact Report
HEALTH IMPACT REPORT October Monthly Health Impact Report OCTOBER, PSI AVERTED AN ESTIMATED 17,899,945 DALYs (88% of the strategic target, the goal is 80%). This is a 66% increase from. Oct. 11 DALYs averted
More informationFebruary Health Impact Report 2010
February Health Impact Report 1,391,742 Feb'10 DALYs: 7.5% of strategic target goal is 14% 26% decrease from Feb'09 Feb' 10 DALYs include: :: 1,350,675 product s :: 41,067 BCC DALYs todate in 9 countries:
More informationAnnex 2 A. Regional profile: West Africa
Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262
More informationCurrent State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2
Current State of Global HIV Care Continua Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2 1) International Association of Providers of AIDS Care
More informationEligibility List 2018
The Global Fund s 2017-2022 strategy and allocation-based approach enables strategic investment to accelerate the end of HIV/AIDS, tuberculosis and malaria and build resilient and sustainable systems for
More information2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS
2015 CONTRACEPTIVE SOCIAL MARKETING STATISTICS November 2016 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington, DC 20006 1 SOCIAL MARKETING STATISTICS 2015 Highlights
More informationCONTRACEPTIVE SOCIAL MARKETING STATISTICS
2016 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2017 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington DC 20006 SOCIAL MARKETING STATISTICS 2016 Highlights 2016
More informationCONTRACEPTIVE SOCIAL MARKETING STATISTICS
2017 CONTRACEPTIVE SOCIAL MARKETING STATISTICS September 2018 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington DC 20006 SOCIAL MARKETING STATISTICS 2017 Highlights 2017
More informationCONTRACEPTIVE SOCIAL MARKETING STATISTICS
2016 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2017 CONNECT WITH US Courtesy of DKT International 1701 K Street, NW Suite 900 Washington DC 20006 SOCIAL MARKETING STATISTICS 2016 Highlights 2016
More information2002 CONTRACEPTIVE SOCIAL MARKETING STATISTICS
2002 CONTRACEPTIVE SOCIAL MARKETING STATISTICS Courtesy of DKT International 1120 19th Street, NW Suite 610 July 2003 Washington, DC 20036 1 SOCIAL MARKETING STATISTICS 2001 Highlights 2002 2001 2000 CYPs
More information2006 CONTRACEPTIVE SOCIAL MARKETING STATISTICS
2006 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2007 Courtesy of DKT International 1701 K Street, NW Suite 900 Washington, DC 20006 www.dktinternational.org 1 SOCIAL MARKETING STATISTICS 2006 Highlights
More informationEXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT
UNICEF / Zar Mon Annexes EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT This report includes nine nutrition statistics, as per the 2017 Global Nutrition Report. These
More information2007 CONTRACEPTIVE SOCIAL MARKETING STATISTICS
2007 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2008 Courtesy of DKT International 1701 K Street, NW Suite 900 Washington, DC 20006 www.dktinternational.org 1 SOCIAL MARKETING STATISTICS 2007 Highlights
More informationGlobal Fund ARV Fact Sheet 1 st June, 2009
Global Fund ARV Fact Sheet 1 st June, 2009 This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown
More informationSexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions
Core competencies in primary care: Supplement 2 Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions The Core competencies in
More informationComparative Analyses of Adolescent Nutrition Indicators
Comparative Analyses of Adolescent Nutrition Indicators Rukundo K. Benedict, PhD The DHS Program Stakeholders Consultation on Adolescent Girls Nutrition: Evidence, Guidance, and Gaps October 30 31, 2017
More informationJOINT TB AND HIV PROGRAMMING
JOINT TB AND HIV PROGRAMMING Haileyesus Getahun, WHO. On behalf of the Global Fund Interagency TB and HIV Working Group (Global Fund, PEPFAR, Stop TB Partnership, UNAIDS, WHO) I was admitted in a hospital
More informationGlobal Fund Results Fact Sheet Mid-2011
Global Fund Results Fact Sheet Mid-2011 This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach
More informationTHE CARE WE PROMISE FACTS AND FIGURES 2017
THE CARE WE PROMISE FACTS AND FIGURES 2017 2 SOS CHILDREN S VILLAGES INTERNATIONAL WHERE WE WORK Facts and Figures 2017 205 58 79 families and transit 31 Foster homes 162 8 3 173 214 2 115 159 136 148
More informationSGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:
SGCEP SCIE 1121 Environmental Science Spring 2012 Section 20531 Steve Thompson: steventhompson@sgc.edu http://www.bioinfo4u.net/ 1 First, a brief diversion... Into... how to do better on the next exam,
More information2009 CONTRACEPTIVE SOCIAL MARKETING STATISTICS
2009 CONTRACEPTIVE SOCIAL MARKETING STATISTICS September 2010 Courtesy of DKT International 1701 K Street, NW Suite 900 Washington, DC 20006 www.dktinternational.org 1 SOCIAL MARKETING STATISTICS 2009
More informationTipping the dependency
BREAKING NEWS Meeting the investment challenge Tipping the dependency balance Domestic investments exceed international investments total reaching US$ 8.6 billion. 40 countries fund more than 70% of their
More information2010 CONTRACEPTIVE SOCIAL MARKETING STATISTICS
2010 CONTRACEPTIVE SOCIAL MARKETING STATISTICS August 2011 Courtesy of DKT International 1701 K Street, NW Suite 900 Washington, DC 20006 www.dktinternational.org 1 SOCIAL MARKETING STATISTICS 2010 Highlights
More informationFamily Planning: Succeeding in Meeting Needs To Make a Better World. Amy Tsui April 12, 2011
Family Planning: Succeeding in Meeting Needs To Make a Better World Amy Tsui April 12, 2011 Family Planning, One of the Ten Best Public Health Achievements of the 20 th Century and Now Remarkable health
More informationANNEX 3: Country progress indicators
: progress indicators 541 : COUNTRY PROGRESS INDICATORS 2006 REPORT ON THE GLOBAL AIDS EPIDEMIC Annex 3 : COUNTRY PROGRESS INDICATORS As of March 2006, 115 countries had reported indicators on progress
More informationGlobal Fund Mid-2013 Results
Global Fund Mid-2013 Results This fact sheet outlines some of the common questions and answers regarding results reported by Global Fund-supported programs, including the principles and approach in determining
More informationPneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division
Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates
More informationBCG. and your baby. Immunisation. Protecting babies against TB. the safest way to protect your child
BCG and your baby Protecting babies against TB Immunisation the safest way to protect your child This leaflet is about the BCG (Bacillus Calmette-Guerin) vaccination that is being offered to protect your
More informationChallenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?
Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030? Reuben Granich, MD, MPH Strategic and Scientific Advisor International
More informationMain global and regional trends
I N T R O D U C T I O N Main global and regional trends Promising developments have been seen in recent years in global efforts to address the AS epidemic, including increased access to effective treatment
More informationICM: Trade-offs in the fight against HIV/AIDS
ICM: Trade-offs in the fight against HIV/AIDS 1 As the HIV/AIDS pandemic enters its 25 th year, both the number of infections and number of deaths due to the disease continue to rise. Despite an enormous
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN 978-92-9173-945-5 UNAIDS / JC2225E The designations employed and the presentation of
More informationFinancing malaria control
Chapter 6. Financing malaria control The three major sources of funds for malaria control pro - grammes are national government spending, external assistance from donors and household or private out-of-pocket
More informationCopyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved
UNAIDS DATA TABLES 2011 Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved UNAIDS / JC2225E The designations employed and the presentation of the material in this publication
More informationMalaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA
Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?
More informationUNAIDS Office on AIDS, Security and Humanitarian Response; Initiative on HIV/AIDS and Uniformed Services, with special emphasis on young recruits
REGIONS COUNTRY PROJECT DESCRIPTION MONITORING / South and South East Cambodia Bangladesh UNAIDS to support HIV/AIDS prevention activities for Demobilizing personnel UNAIDS to support HIV/AIDS prevention
More informationLessons learned from the IeDEA West Africa Collaboration
Lessons learned from the IeDEA West Africa Collaboration François DABIS with the contribution of Didier Koumavi EKOUEVI INSERM U-897, Bordeaux, France, Programme PACCI, ANRS site, Abidjan, Côte d Ivoire
More informationVarious interventions for controlling sexually transmitted infections have proven effective, including the syndromic
levels, as understaffing is a chronic issue in all the countries that are scaling up male circumcision. Current achievements notwithstanding, it is necessary to reinforce and strengthen national political
More informationFunding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia
Funding for AIDS: The World Bank s Role Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Outline New resources needs estimates Bridging the gap Global overview of
More informationAPPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS
WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC, 2011 APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS (SEE TABLE 4.9) Africa The Americas South-East Asia Europe Eastern Mediterranean Western Pacific
More informationGlobal summary of the AIDS epidemic, December 2007
Global summary of the AIDS epidemic, December 27 Number of people living with HIV in 27 Total Adults Women Children under 15 years 33.2 million [3.6 36.1 million] 3.8 million [28.2 33.6 million] 15.4 million
More informationמדינת ישראל. Tourist Visa Table
Updated 23/05/2017 מדינת ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. Exe = exempted Req = required Press the first
More informationSeizures of ATS (excluding ecstasy ), 2010
Seizures of ATS (excluding ecstasy ), 2010 (countries and territories reporting seizures* of more than 10 kg) 9 5.1 8.7 12.9 Ghana Armenia 0.7 9.9 1 2.1 Syrian Arab Republic Korea (Republic of) Iraq Islamic
More informationSourcing of ARVs & HIV diagnostics. Procurement for Impact P4i
Sourcing of ARVs & HIV diagnostics Procurement for Impact P4i AMDS ANNUAL STAKEHOLDERS AND PARTNERS MEETING 29 September 2014 Global Fund: Procurement for Impact: P4i Our objective was straightforward:
More informationUpdate from GAVI Aurelia Nguyen
Update from GAVI Aurelia Nguyen (Copenhagen, Denmark, 27 June 2012) GAVI vaccine support Currently supported vaccines: pentavalent, pneumococcal, rotavirus, meningitis A, human papillomavirus (HPV), rubella,
More informationמדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.
Updated 25/05/2015 ישראל Tourist Visa Table Tourist visa exemption is applied to national and official passports only, and not to other travel documents. (C) Bearers of official passports requiring tourist
More informationDrug Prices Report Opioids Retail and wholesale prices * and purity levels,by drug, region and country or territory (prices expressed in US$ )
1 / 11 Region/Subregion/ Country Africa Eastern Africa Kenya Madagascar Mauritius Uganda United Republic of Tanzania Northern Africa Algeria Egypt Libya Morocco Sudan Southern Africa Botswana Burkina Faso
More informationMaternal Deaths Disproportionately High in Developing Countries
EMBARGOED until Monday, 20 October, 6am GMT HQ/2003/24 20 October 2003 CF/DOC/PR/2003-82 Maternal Deaths Disproportionately High in Developing Countries African women are 175 times more likely to die in
More informationEpidemiology and economics: modelling the scenarios for the end of AIDS
Epidemiology and economics: modelling the scenarios for the end of AIDS Controlling the HIV Epidemic with Antiretrovirals: from consensus to implementations London, England September 22, 2013 Reuben Granich,
More informationDiagnostic Procurement The Clinton Foundation HIV/AIDS Initiative
Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative 28 October 2008 Geneva 1 CHAI Work in Diagnostics - Context Diagnostic Test Agreements - In 2002 when CHAI was formed, the price of many
More informationWorld Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts
World Health organization/ International Society of Hypertension (WH0/ISH) risk prediction charts (charts in colour) (These charts will be updated in 2014) 2 1. Introduction 2. Instructions on how to use
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationOutcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations
Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations Briefing on Xpert MTB/RIF. Geneva, 21 February, 2011 Fuad Mirzayev TB Laboratory Strengthening and Diagnostics
More information1. Consent for Treatment This form must be completed in order to receive healthcare services in the campus clinic.
HEALTH & WELLNESS SERVICES INSTRUCTIONS FOR COMPLETING THE REQUIRED MEDICAL FORMS FOR: U.S. CITIZENS 18 YEARS OF AGE OR OLDER AT THE TIME THE FORMS ARE COMPLETED. THIS REQUIREMENT MUST BE COMPLETED WHETHER:
More informationDonor Support for Contraceptives and Condoms for STI/HIV Prevention
Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2001 Donor Support for Contraceptives and Condoms for STI/HIV Prevention 2001 Table of Contents List of Abbreviations and Acronyms List
More informationCOLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)
COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) Sushila Maharjan Senior Manager, Innovative Finance International Conference on Sustainable Cooling World Bank Washington DC - 29 November 2018 Reach
More informationD TA companion & Scorecard. to the UNICEF Gender Action Plan. May 2016
D TA companion & Scorecard to the UNICEF Gender Action Plan May 216 Selected indicators from the UNICEF Strategic Plan 214 217 Prepared by Data, Research and Policy United Nations Children s Fund 3 United
More information#1 #2 OR Immunity verified by immune titer (please attach report) * No titer needed if proof of two doses of Varicella provided
Student Information: Date of Birth: There are two ways to provide us with your immunization information. 1) Students can have their healthcare provider fill out and sign the form below. A healthcare provider
More informationThe Global HIV/AIDS Epidemic, risk factors for transmission. and Global response. Training Course in Sexual and Reproductive Health Research 2014
The Global HIV/AIDS Epidemic, risk factors for transmission and Global response Training Course in Sexual and Reproductive Health Research 2014 Txema Calleja HIV Dept. July 2014 Data based in UNAIDS and
More informationHIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR
HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR 2015 2020 Presented by Vincent Habiyambere (WHO), Biyi Adesina (Avenir Health) and Meghan Wareham (CHAI) on behalf
More informationRotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division
Rotavirus Vaccine: & Demand Update UNICEF Division July 0 Rotavirus Vaccine (RV): & Demand Update July This update provides new information on countries and their scheduled RV introductions, forecasted
More informationTHE FUTURE OF ADULT MORTALITY UNDER THE AIDS THREAT: ESTIMATING AND PROJECTING INCIDENCE; PROJECTING MORTALITY WITH HIV/AIDS *
UN/POP/MORT/2003/11 2 September 2003 ENGLISH ONLY WORKSHOP ON HIV/AIDS AND ADULT MORTALITY IN DEVELOPING COUNTRIES Population Division Department of Economic and Social Affairs United Nations Secretariat
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationUpdate on progress of MPP sublicensees
Update on progress of MPP sublicensees Medicines Patent Pool SEPTEMBER 2018 SUMMARY This presentation showcases the progress made by MPP licensees (generic pharmaceutical companies) To date, MPP has signed
More informationIX. IMPROVING MATERNAL HEALTH: THE NEED TO FOCUS ON REACHING THE POOR. Eduard Bos The World Bank
IX. IMPROVING MATERNAL HEALTH: THE NEED TO FOCUS ON REACHING THE POOR Eduard Bos The World Bank A. INTRODUCTION This paper discusses the relevance of the ICPD Programme of Action for the attainment of
More informationAIDS in Africa. An Update. Basil Reekie
AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the
More informationWhat is this document and who is it for?
Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationThis portion to be completed by the student Return by July 1 Please use ballpoint pen
This portion to be completed by the student Return by July 1 Please use ballpoint pen Start term: Fall Exploration Spring Summer Year: Class year: Freshman Sophomore Junior Senior Transfer Full name: Preferred:
More informationCertificate of Immunization
Certificate of Immunization Required of all students (Page 1 of 5) QUESTIONS? 440-775-8180 or student.health@oberlin.edu (e-mail preferred) RETURN TO: Oberlin College Student Health Services 247 W. Lorain
More informationEnding the AIDS Epidemic in Adolescents
Ending the AIDS Epidemic in Adolescents Eastern and Southern Africa Regional Update on the ALL IN Overview 13 October 2015 AIDS-related deaths has declined for all age groups Except adolescents! Eastern
More informationMalnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, 2000)
Recent trends in malnutrition in developing regions 109 Annex 1 Malnutrition prevalences by country and year, from survey data and interpolated for reference years (1990, 1995, ) The tables in this Annex
More informationThe Private Sector: Key to Achieving Family Planning 2020 Goals
The Sector: Key to Achieving Family Planning 2020 Goals As family planning stakeholders look to accelerate progress toward Family Planning 2020 goals, the private health sector presents a significant opportunity
More informationUNAIDS 2017 REFERENCE UNAIDS DATA 2017
UNAIDS 2017 REFERENCE UNAIDS DATA 2017 Copyright: 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material in this publication
More informationUNAIDS 2017 REFERENCE UNAIDS DATA 2017
UNAIDS 2017 REFERENCE UNAIDS DATA 2017 Copyright: 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material in this publication
More informationWORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT
WORLD COUNCIL OF CREDIT UNIONS 2017 STATISTICAL REPORT THE GLOBAL NET WORK OF CREDIT UNIONS AND FINANCIAL COOPERATIVES MEMBERSHIP AT A GLANCE World Council builds, champions, defends and grows a global
More informationUNAIDS 2017 REFERENCE UNAIDS DATA 2017
UNAIDS 2017 REFERENCE UNAIDS DATA 2017 Copyright: 2017 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved. The designations employed and the presentation of the material in this publication
More informationMethodological issues in the use of anthropometry for evaluation of nutritional status
Methodological issues in the use of anthropometry for evaluation of nutritional status Mercedes de Onis WHO Department of Nutrition Time schedule child anthropometry Measurement Time frame Frequency
More informationRotavirus vaccines: Issues not fully addressed in efficacy trials
Rotavirus vaccines: Issues not fully addressed in efficacy trials TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines Licensed in 2006
More informationO c t o b e r 1 0,
STUDENT VOICES FROM THE FIELD: WORLD HEALTH ORGANIZATION GENEVA, SWITZERLAND O c t o b e r 1 0, 2 0 1 6 M o l l y P e z z u l o University at Albany School of Public Health MPH Epidemiology Candidate 17
More informationTo Tie the Knot or Not: A Case for Permanent Family Planning Methods
To Tie the Knot or Not: A Case for Permanent Family Planning Methods Presented at the GH Mini-University Washington, D.C., October 8, 2010 By Lynn Bakamjian, MPH Project Director, RESPOND/EngenderHealth
More informationAccess to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities
#IAS2017 @IAS_conference Access to Stigma-Free Healthcare Settings for Key Populations: Challenges and Opportunities Dr. R. Cameron Wolf Senior HIV/AIDS Advisor for Key Populations U.S. Agency for International
More informationUpdate on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012
PMTCT Update Update on PMTCT Margarett Davis, MD, MPH Chief, Maternal and Child Health Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention (CDC) African Health Profession Regulatory
More informationPresentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development
Presentation by Dr Philippe Douste-Blazy Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development The Millennium Goals : Hope for Humanity 2000 UN Millennium Summit
More informationDATA COMPANION & & SCORECARD. to the UNICEF Gender Action Plan. May 2017
DATA COMPANION & & SCORECARD to the UNICEF Gender Action Plan May 217 Selected indicators from the UNICEF Strategic Plan, 214 217 Prepared by Data, Research and Policy United Nations Children s Fund 3
More informationAnalysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),
Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF), 2008-2010 Claudio Politi and Oumar Sagna Department of Immunization Vaccines and Biologicals, World Health
More informationElimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014
Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child
More informationHIV in Women: A Global View of the HIV Epidemic
HIV in Women: A Global View of the HIV Epidemic George Schmid, M.D., M.Sc. Department of HIV/AIDS World Health Organization Geneva, Switzerland Schmidg@who.int Training Course in Sexual and Reproductive
More informationU.S. Funding for International Family Planning & Reproductive Health
April 2016 Issue Brief U.S. Funding for International Family Planning & Reproductive Health SUMMARY The U.S. government has supported international family planning and reproductive health (FP/RH) efforts
More informationMATERNAL, NEWBORN, AND CHILD HEALTH
MATERNAL, NEWBORN, AND CHILD HEALTH SESSION OBJECTIVES Introduction to GHSC-PSM Maternal, Newborn, and Child Health (MNCH) strategy and priorities Defining MNCH commodities Overview of historical and current
More informationPROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA
5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR
More informationHIV in Women: A Global View of the HIV Epidemic
Training Course in Reproductive Health / Sexual Health Research Geneva 2006 HIV in Women: A Global View of the HIV Epidemic George Schmid, M.D., M.Sc. Department of HIV/AIDS World Health Organization Geneva,
More information